EVOGENE LTD (EVGN:NASDAQ)
$0.5281 0.0333 (6.73%)
Analysed EVOGENE LTD (EVGN:NASDAQ) News Sources
Evogene Reports Second Quarter and First Half 2026 Financial Results
18-08-2026
yahoo.com
Evogene Ltd (EVGN) (Q2 2026) Earnings Call Highlights: Strategic Pivot to AI-Driven Drug ...
18-08-2026
yahoo.com
EverGen Infrastructure Announces Voting Results for the Annual General Meeting of Shareholders Held on August 25, 2026
26-08-2026
yahoo.com
EverGen Infrastructure Reports Q2 2026 Results
27-08-2026
yahoo.com
Evogene and ELEO to develop new oral PCSK9 inhibitors
23-07-2026
pharmaceutical-technology.com
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
14-08-2026
yahoo.com
Evogene Ltd. Q2 2026 Earnings Call Summary
19-08-2026
moby.co
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees
25-08-2026
yahoo.com
Evogene (EVGN) Q2 2026 Earnings Call Transcript
25-08-2026
fool.com
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
31-08-2026
yahoo.com
What is the current price of EVOGENE LTD (EVGN:NASDAQ)?
The current price of EVOGENE LTD (EVGN:NASDAQ) is $0.5281.
EVOGENE LTD (EVGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of EVOGENE LTD (EVGN:NASDAQ) since the previous trading day is $0.0333.
EVOGENE LTD (EVGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of EVOGENE LTD (EVGN:NASDAQ) since the previous trading day is 6.73%.
What is the most recent average sentiment score for EVOGENE LTD (EVGN:NASDAQ)?
The most recent average sentiment score for EVOGENE LTD (EVGN:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for EVOGENE LTD (EVGN:NASDAQ)?
The most recent sentiment for EVOGENE LTD (EVGN:NASDAQ) is .
SEC-8K** Filing Available For EVOGENE LTD (EVGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.